- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04796246
Leap Motion Controller on the Functionality of Upper Limbs in Parkinson's Disease
Leap Motion Controller on the Functionality Of Upper Limbs in Parkinson's Disease: A Randomized Clinical Trial
Is treatment with the Leap Motion Controller device effective for upper limb functionality in individuals with Parkinson's Disease?
The present study presents two hypotheses:
True hypothesis: There is an improvement in the functionality of MMSS after intervention with virtual reality? Null hypothesis: There is no improvement in the functionality of MMSS after intervention with virtual reality? The proposed work will be characterized as a Randomized Clinical Trial, with evaluators outside the experimental groups (single-blind). The sample will be probabilistic, from individuals diagnosed with Parkinson's disease.
Study Overview
Status
Intervention / Treatment
Detailed Description
STUDY METHODOLOGY
- RESEARCH DESIGN: The proposed work will be characterized as a Randomized Clinical Trial, with evaluators outside the experimental groups (single-blind). The sample will be probabilistic, from individuals diagnosed with Parkinson's disease.
- TYPE OF STUDY: Randomized Clinical Trial.
- AREA OF SCOPE: Major area: Health Sciences. Area: Physiotherapy and Occupational Therapy.
- LOCATION: The place where the entire study will be carried out will be in the home environment of each research participant.
- PARTICIPANTS: Participants will be recruited from an existing pre-existing list of research conducted on individuals with Parkinson's Disease from the UFCSPA. Individuals who: - are diagnosed with Parkinson's disease; - Classified as I-III on the Hoehn & Yahr motor staging scale; - Are over 18 years old (above this, without age restriction). - Residents in the city of Porto Alegre / RS. - Have signed the informed consent form (Appendix A). Individuals who: - Do not show the understanding of the games on the first day of familiarization; - Have a cerebral pacemaker implant; - Have recent injuries or limitations that make the MMSS impossible. - Do not perform / abstain from two appointments out of the 16 proposed in the intervention protocol, regardless of the group that will be allocated. The study will consist of two groups: intervention group (IG), which will receive treatment with Leap Motion Controller; and the control group (CG), who will receive treatment with conventional physiotherapy.
- EVALUATION INSTRUMENTS: A participant identification form will be filled out, containing full name, date of birth, gender, address, telephone number, education, diagnosis, time of diagnosis, onset of symptoms (laterality), associated diseases, PD subtype and medicines. Individuals will be assessed for: the motor aspects of experiences and activities of daily living using the TEMPA test and the Unified Assessment Scale for Parkinson's Disease (MDS-UPDRS) part II; Motor Assessment and subtype of the disease, using the MDS-UPDRS scale III; motor staging of PD using the Hoehn & Yahr scale; muscle strength and endurance, using the handgrip dynamometer (TEMPA test); manual dexterity, through the Box and Block test and the Nine Hole Peg test; cognitive issues through the Montreal Cognitive Assessment (MoCA); and quality of life, through the Questionnaire on Parkinson's Disease (PDQ-39).
- EXPECTED DURATION: The present research project contemplates different objectives, this being a study proposal to be developed during four years.
- PROCEDURES: The formation of each of the groups will be done through the generation of a random sequence through the tool available at http://www.randomize.com. Therefore, individuals will be divided into two groups: Intervention Group and Control Group. Subsequently, the initial assessment will be made,TEMPA, MDS-UPDRS-II e III, motor staging of the disease (H&Y), Box and Block Test, Nine Hole Peg Test), MoCA and PDQ-39.The IG will carry out a 2-month intervention protocol, with 16 40-minute interventions, twice a week. The CG will perform a conventional physiotherapy protocol for the same period as the IG. Therefore, all groups will receive the same evaluation procedures that will be performed before the intervention (PRE), after the intervention (POST) and, finally, 30 days after the intervention (follow-up). The researchers responsible for the intervention will not be aware of the evaluations carried out and the evaluators will not be aware of the group to which the participant will belong. Both groups will be able to follow their routine activities (physical and / or physical therapy) and all procedures will be performed in the home environment of each research participant.
- ETHICAL AND LEGAL PROCEDURES The study project in question will be submitted to the Research Ethics Committee of the Federal University of Health Sciences of Porto Alegre (UFCSPA) and will only be applied after due approval. All participants will be informed about the procedures, objectives, justifications, potential risks and benefits of their participation in the study. The research will not present risks to the participant, but if there is any discomfort during any activity, the treatment will be stopped immediately and the necessary measures taken. In addition, all participants must sign the informed consent form and receive a copy of it. The use of any type of image will not identify the participant and will only be used with written consent. The data in the medical record (name, telephone and address) will be used for screening in the identification and contact of individuals and stored in a database that will be accessed only by researchers.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: PHILIPE S CORREA, Ms
- Phone Number: 51981502565
- Email: philipesc@ufcspa.edu.br
Study Contact Backup
- Name: Cechetti Fernanda
- Phone Number: 51981502565
- Email: fernandacec@ufcspa.edu.br
Study Locations
-
-
RIO Grande DO SUL
-
Porto Alegre, RIO Grande DO SUL, Brazil, 55
- Philipe Souza Correa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Parkinson's disease diagnostic;
- Classified as I-III on the Hoehn & Yahr motor staging scale;
- Are over 18 years old (above this, without age restriction).
- Residents in the city of Porto Alegre / RS.
- Have signed an informed consent form.
Exclusion Criteria:
- Do not show the understanding of the games on the first day of familiarization;
- Have a cerebral pacemaker implant;
- Have recent injuries or limitations that make the MMSS impossible.
- Do not perform / abstain from two appointments out of the 16 proposed in the intervention protocol, regardless of the group that will be allocated.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Leap Motion Controller
Intervention Group: which will receive treatment with Leap Motion Controller
|
Training with the Leap Motion Controller instrument will be carried out first for 5 minutes, for a presentation and interaction of the virtual immersion with it, in the initial meeting.
After the second meeting, the attendance protocol will be 16 sessions, this time being distributed as: first game lasting 7 minutes, second and third games lasting 6 minutes each and the last game lasting 8 minutes, totaling 27 minutes of intervention.
Between games it was adopted about 2 minutes of rest.
The conventional physiotherapy intervention will be based on the same activities developed (MMSS movements) of the IG: - First, attach pins with magnets with moving disc and after 1 minute and 25 seconds remove flower petals from inside a tube.
The movements performed will be fine motricity, related to the tweezers handling (thumb and forefinger), alternating hands after 2 minutes and 30 minutes of play; - Hitting your hands on suddenly raised rulers, performing bilateral flexion / extension movements of the wrist simultaneously and alternating hands after 2 minutes and 30 minutes of play.
|
Active Comparator: Conventional Physiotherapy
Control Group: who will receive treatment with conventional physiotherapy.
|
Training with the Leap Motion Controller instrument will be carried out first for 5 minutes, for a presentation and interaction of the virtual immersion with it, in the initial meeting.
After the second meeting, the attendance protocol will be 16 sessions, this time being distributed as: first game lasting 7 minutes, second and third games lasting 6 minutes each and the last game lasting 8 minutes, totaling 27 minutes of intervention.
Between games it was adopted about 2 minutes of rest.
The conventional physiotherapy intervention will be based on the same activities developed (MMSS movements) of the IG: - First, attach pins with magnets with moving disc and after 1 minute and 25 seconds remove flower petals from inside a tube.
The movements performed will be fine motricity, related to the tweezers handling (thumb and forefinger), alternating hands after 2 minutes and 30 minutes of play; - Hitting your hands on suddenly raised rulers, performing bilateral flexion / extension movements of the wrist simultaneously and alternating hands after 2 minutes and 30 minutes of play.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Test TEMPA (Test d'Évaluation des Membres Supérieurs de Personnes Agées)
Time Frame: Pre and Post Immediate intervention. 30 days after interventions.
|
It is an instrument that serves to assess the degree of disability of the MMSS.
It presents a manual on how to manage it, the necessary measures to make the box and where to dispose of each specific material of the tasks.
The materials required for administering the test are as follows: 100 gram coffee pot, 1000 milliliter water jar, coffee spoon, cup, water glass, medicine bottle and 10 placebo capsules, white envelopes, seal, pencil , card game, coins (R $ 1, R $ 0.25, R $ 0.50, R $ 0.10), small glass jar (7 cm (cm) in diameter and 5 cm in height), small objects (toothpick, nut, safety pin, 2.5 cm diameter button and nail), piece of non-slip material and sheets for recording scores (MICHAELSEN et al., 2008).
The test consists of performing bilateral and unilateral tasks, of the upper limbs.
|
Pre and Post Immediate intervention. 30 days after interventions.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
Time Frame: Pre and Post Immediate intervention. 30 days after interventions.
|
The updated MDS-UPDRS scale comprises four parts: Part I, the impact of non-motor aspects of daily life, part II, motor aspects of daily life, part III, motor assessment and part IV that corresponds to motor complications.
However, only part II - motor aspects of daily life will be applied, which is designed to be a self-administered questionnaire, but can be reviewed by the researcher to ensure its clear and complete completion.
And part III - motor evaluation, in which it has instructions for the evaluator to provide or demonstrate to the individual and is completed by the evaluator.
A higher score corresponds to a corresponding worse state.
|
Pre and Post Immediate intervention. 30 days after interventions.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hoehn & Yahr Scale
Time Frame: Pre and Post Immediate intervention. 30 days after interventions.
|
The Hoehn & Yahr (H&Y) staging scale serves to classify and determine which motor stage of Parkinson's disease the individual is in.
It is an easy and quick scale to be applied, which has its modified form, comprising five stages of classification to assess the severity of PD, and is based mainly on the signs and symptoms to assess the individual's level of disability.
Individuals rated on the scale between one and three are in stages of mild to moderate disability, while those with stages four and five fall into severe disability.
|
Pre and Post Immediate intervention. 30 days after interventions.
|
Box and Block Test
Time Frame: Pre and Post Immediate intervention. 30 days after interventions.
|
For the application of the manual dexterity test, a wooden box with a length of 53.7 cm is required, with a partition also made of wood higher than the edges of the box, separating it into two compartments of equal dimensions.
The blocks also made of wood and in the form of colored cubes (primary colors) of 2.5 cm on a side are 150 in number, divided equally by color.
As a prerequisite for the application of the test, a quiet environment is necessary, with the subject being seated in a chair suitable for his / her height.
The box must be placed horizontally in front of him so that he has a full view of the area and equipment in question.
|
Pre and Post Immediate intervention. 30 days after interventions.
|
Nine Hole Peg Test
Time Frame: Pre and Post Immediate intervention. 30 days after interventions.
|
The test that assesses manual dexterity consists of nine pins and a plate with nine holes, in which the individual is instructed to take one pin at a time and insert it into the holes contained in the plate and then, later remove the pins and return it.
them to the place of origin.
The execution time is timed by the researcher.
|
Pre and Post Immediate intervention. 30 days after interventions.
|
Montreal Cognitive Assessement - MoCA
Time Frame: Pre and Post Immediate intervention. 30 days after interventions.
|
The MoCA measures eight cognitive domains, which are scored within a range of 0 to 30 points (higher scores indicating better function): short-term memory (delayed recall, 5 points); visuospatial skills (cube design, 1 point, clock design, 3 points); executive function (trail test, 1 point; phonemic verbal fluency, 1 point; verbal abstraction, 2 points); attention, concentration and working memory (cancellation, 1 point; subtraction, 3 points; digit range, 2 points); language (nomination, 3 points; sentence repetition, 2 points); and orientation in time (3 points) and space (3 points).
|
Pre and Post Immediate intervention. 30 days after interventions.
|
Parkinson's Disease Questionnaire - PDQ-39
Time Frame: Pre and Post Immediate intervention. 30 days after interventions.
|
The Parkinson's Disease questionnaire, PDQ-39, consists of 39 questions covering the topics: mobility, activities of daily living, emotional well-being, social support, body discomfort, stigma, cognition and communication.
The individual identifies how often in the last month he found himself in the situations mentioned.
The options are never (0 points), rarely (1 point), sometimes (2 points), often (3 points) and always (4 points).
Between 0 and 100 the lowest score corresponds to the highest quality of life.
|
Pre and Post Immediate intervention. 30 days after interventions.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24443019.7.0000.5345
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Leap Motion Controller
-
Fernanda CechettiRecruiting
-
Federal University of Health Science of Porto AlegreNot yet recruitingParkinson DiseaseBrazil
-
IRCCS Burlo GarofoloCompletedProcedural Pain | VenipunctureItaly
-
Istanbul UniversityNot yet recruitingScleroderma, Systemic | Rehabilitation | Physiotherapy | Rheumatology | Hand Rheumatism | Video Games
-
Istanbul UniversityThe Scientific and Technological Research Council of TurkeyCompletedRehabilitation | Physical Therapy
-
Universidad Rey Juan CarlosUnknownStroke | Brain Injuries, Traumatic | Treatment Adherence | Patient SatisfactionSpain
-
Istanbul UniversityCompleted
-
Istanbul Medipol University HospitalCompleted
-
Instituto de Investigación Hospital Universitario...Universidad Politecnica de Madrid; Hospital Universitario La PazRecruiting
-
Saime Nilay ArmanCompleted